Literature DB >> 1783472

Comparative immunopharmacology and toxicology of the bisbenzylisoquinoline alkaloids tetrandrine and berbamine.

C W Wong1, W K Seow, T S Zeng, W J Halliday, Y H Thong.   

Abstract

Comparison of the bisbenzylisoquinolines tetrandrine and berbamine shows that both drugs are equipotent in terms of enhancement of antibody responses and suppression of delayed-type hypersensitivity (DTH) responses to sheep red blood cell antigens. Both compounds are also equally active when given to mice during the induction and expression phases of DTH. Using a model of experimental brucellosis in mice, it was found that both compounds did not affect antibody responses, while they caused equipotent suppression of DTH. By contrast, berbamine but not tetrandrine caused significant suppression of spleen weight. Also, berbamine caused a significantly greater enhancement of spleen colony counts of Brucella abortus than tetrandrine. Short-term toxicology studies showed no toxic effects at bioactive doses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1783472     DOI: 10.1016/0192-0561(91)90079-m

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor.

Authors:  C W Wong; W K Seow; J W O'Callaghan; Y H Thong
Journal:  Agents Actions       Date:  1992-05

2.  A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3.

Authors:  Ruoqiu Fu; Qin Deng; Hongwei Zhang; Xiaoye Hu; Yunong Li; Yanxia Liu; Jinjiao Hu; Qingsong Luo; Yanhao Zhang; Xiuxing Jiang; Lirong Li; Chong Yang; Ning Gao
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

3.  Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha.

Authors:  W K Seow; K Nakamura; Y Sugimura; Y Sugimoto; Y Yamada; D P Fairlie; Y H Thong
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.